Normal Tissue Reactions in Mice after Combined Treatment with Metoclopramide and Ionizing Radiation

References

• Kjellen E, Wennerberg J, Pero R. Metoclopramide enhances effect of cisplatin on xenografted squamous cell carcinoma of the head and neck. Br J Cancer 1989; 59: 247–50
   PubMed Web of Science ®Google Scholar
• Lybak S, Kjellén E, Wennerberg J, Pero R W. Metoclopramide enhances the effect of ionizing radiation on xenografted squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1990; 19: 1419–24
   PubMed Web of Science ®Google Scholar
• Gralla R J, Itri L M, Pisko S E, et al. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med 1981; 305: 905–9
   PubMed Web of Science ®Google Scholar
• Kris M G, Gralla R J, Tyson L B, Clark R A, Bosl G J, Kalman L A. Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metocloprdmide, dexamethasone, and diphenhydramine. Cancer 1985; 55: 527–34
   PubMed Web of Science ®Google Scholar
• Nduka M L, Skidmore C J, Shall S. The enhancement of cytotoxicity of N-methyl-N-nitrosourea and of radiation by inhibitors of poly (ADP-ribose) polymerase. Eur J Biochem 1980; 105: 525–30
   PubMedGoogle Scholar
• George A M, Lunec J., Cramp W A, Brennan S, Lewis P D, Whish W JD. The effects of benzamide ADP-ribosyl transferase inhibitors on cell survival and DNA strand break repair in radiated mammalien cells. Int J Radiat Biol 1985; 49: 783–98
   Web of Science ®Google Scholar
• Horsman M R, Brown D M, Lemmon M J, Brown J M, Lee W W. Preferential tumor radiosensitization by analoges of nicotinamide and benzamide. Int J Radiat Oncol Biol Phys 1986; 12: 1307–10
   PubMed Web of Science ®Google Scholar
• Chaplin D J, Trotter M J, Skov K A, Horsman M R. Modification of tumor radiation response in vivo by the benzamide analogue pyrazinamide. Br J Cancer 1990; 62: 561–6
   PubMed Web of Science ®Google Scholar
• Suto M J, Turner W R, Arundel-Suto C M, Werbel L M, Sebolt-Leopold J S. Dihydroisoquinolinones: the design and synthesis of a new series of potent inhibitors of poly (ADP-ribose) polymerase. Anticancer Drug Des 1991; 7: 107–17
   Google Scholar
• Skidmore C J, Davis M I, Goodwin P M, et al. The involvement of poly(ADP-ribose) polymerase in the degradation of NAD caused by irradiation and N-methyl-N-nitrsourea. Eur J Biochem 1979; 101: 135–42
   PubMedGoogle Scholar
• Thraves R J, Mossman K L, Frazier D MT, Dritschilo A. Inhibition of potentially lethal radiation damage repair in normal and neoplastic human cells by 3–aminobenzamide: an inhibitor of poly(ADP-ribossylation). Int J Radiat Oncol Biol Phys 1986; 12: 1541–5
   PubMed Web of Science ®Google Scholar
• Chaplin D J, Horsman M R, Aoki D S. Nicotinamide, fluosol DA and Carbogen: A strategy to reoxygenate acutely and chronically hypoxic cells in vivo. Br J Cancer 1991; 63: 109–13
   PubMed Web of Science ®Google Scholar
• Sims J L, Sikorski G W, Catino D M, Berger S J, Berger N A. Poly(adenosinediphosphoribose) polymerase inhibitors stimulate unscheduled deoxyribonucleic acid synthesis in normal human lymphocytes. Biochemistry 1982; 21: 1813–21
   PubMed Web of Science ®Google Scholar
• Lybak S, Pero R W. The benzamide derivative metoclopramide causes DNA damage and inhibition of DNA repair in human peripheral mononuclear leukocytes at clinically relevant doses. Carcinogenisis 1991; 12: 1613–7
   PubMed Web of Science ®Google Scholar
• Harrington R A, Hamilton C W, Brogben R N, Linkewich J A, Romankiewicz J A, Heel R C. Metoclopramide. An updated review of its pharmacological properties and clinical use. Drugs 1983; 25: 451–94
   PubMed Web of Science ®Google Scholar
• Lybak S, Wennerberg J, Kjellin E, Pero R W. Dose schedule evaluation of metoclopramide as a potentiator of cisplatin and carboplatin treatments of xenografted squamous cell carcinomas of the head and neck. Anticancer Drugs 1991; 2: 375–82
   PubMed Web of Science ®Google Scholar
• Snedecor G W, Cochran W G. Statistical methods, Seventh edition. The Iowa State University Press, Ames, Iowa 1980
   Google Scholar
• Lesser M L, Braun H I, Helson L. Statistical methods for measuring and comparing treatment efficacies: applications to nude mice experimentation. Exp Cell Biol 1980; 48: 126–37
   PubMedGoogle Scholar
• Berman R, Steel G G. Induced and inherent resistance to alkylating agents in human small-cell bronchial carcinoma xenografts. Br J Cancer 1984; 49: 431–6
   PubMed Web of Science ®Google Scholar
• Forsberg J O, Jung B, Larsson B. Radiation response modified by degradable starch microspheres. Experiments on the rat's foot. Acta Radiol Oncol 1978; 17: 199–208
   Google Scholar
• Fowler J F, Kragt K, Ellis R E, Lindop P J, Berry R J. The effect of divided doses of 15 MeV electrons on skin response of mice. Int J Radiat Biol 1965; 9: 241–52
   Web of Science ®Google Scholar
• Douglas B G, Fowler J F. The effect of multiple small doses of x-rays on skin reactions in the mouse foot and a basic interpretation. Radiat Res 1976; 66: 401–26
   PubMed Web of Science ®Google Scholar
• von der Maase H. Effect of cancer chemotherapeutic drugs on the radiation-induced skin reactions in mouse feed. Br J Radiol 1984; 57: 697–707
   PubMed Web of Science ®Google Scholar
• Brown M J. The mechanisms of cytotoxicity and chemosensi-tization by misonidazole and other nitromidazoles. Int J Radiat Oncol Biol Phys 1982; 8: 675–82
   PubMed Web of Science ®Google Scholar
• Hall E J, Astor M, Biaglow J, Parham J C. The enhanced sensitivity of mammalian cells to killing by x-rays after prolonged exposure to several nitroimidazoles. Int J Radiat Oncol Biol Phys 1982; 8: 447–51
   PubMed Web of Science ®Google Scholar
• Siemann D W. Cell survival recovery kinetics in the KHT sarcoma following treatment with five alkylating agents and misonidazole. Int J Radiat Oncol Biol Phys 1982; 8: 619–22
   Google Scholar